Jul 9, 2021
Fourteen leading U.S. drug companies from 2016 to 2020 spent $577 billion on stock buybacks and dividends, $56 billion more than they spent on research and development over the same period, according to a report released by the House Committee on Oversight and Reform.
Mar 8, 2021
Regulators should prohibit health insurers from preventing hospitals and physicians in their networks from directly acquiring and storing drugs used in patient care, according to a white paper released today by AHA.
Feb 4, 2021
Letter to Centers for Medicare & Medicaid Services, expressing deep concerns regarding a series of UnitedHealthcare health plan coverage policies.
Nov 18, 2020
COVID-19 continues to dramatically impact the short- and long-term strategies of hospitals and health systems.
Aug 3, 2020
.webreplay{ border: solid 2px #777; padding: 15px 5px; margin: 0 0 10px 15px; } @media (min-width:360px){ .webreplay{ min-width: 290px; float: right; } } On-demand Webinar MktoForms2.loadForm("//", "734-ZTO-041", 5774); Pharmacy Benefit…
Mar 10, 2020
Amazon continues to grow its partnerships with health care technology companies as it expands its access points with consumers. The latest move: a deal with drug and medical database company First Databank (FDB) that will allow Amazon’s Alexa voice-assistant users to ask for information on the 1,…
Feb 7, 2020
The United States Pharmacopeia (USP) in June 2019 released several new and revised pharmacy compounding standards. Specifically, USP published the final revised version of general chapter (Pharmaceutical Compounding of Sterile Preparations) to accompany the previous released general chapter (…
Feb 6, 2020
A list of items to consider in preparing to comply with new standards for the handling of hazardous drugs set forth in USP general Chapter 800.
Feb 3, 2020
With rising prices for insulin and the costs of many other diabetes-related drugs taking their toll on patients, CVS Health recently announced that its pharmacy benefits management unit CVS Caremark is launching a program to enable employers and payers to offer these medications at no out-of-pocket…
Jan 29, 2020
Join us to learn about the importance of developing a comprehensive enterprise strategy for infusion services to maximize patient care and business growth. We will address reducing gaps in therapy, creating opportunities for optimal patient outcomes, minimizing patient “leakage” from the health…